中文 | English
Return
Total: 19 , 1/2
Show Home Prev Next End page: GO
MeSH:(Receptors, Steroid/*genetics)

1.Pharmacology research on PXR as a potential target in screening bioactive components of Chinese material medica.

Yu-guang WANG ; Xian-xie ZHANG ; Han LI ; Bei-bei LU ; Jian-ming ZHOU ; Hao-sheng LIU ; Dong-hua HU ; Tao ZHOU ; Ya-xin ZHANG ; Zeng-chun MA ; Qian-de LIANG ; Xiang-lin TANG ; Cheng-rong XIAO ; Hong-ling TAN ; Yue GAO

China Journal of Chinese Materia Medica 2015;40(17):3444-3449

2.Transcriptional regulation of cytochrome P450 3A4 by four kinds of traditional Chinese medicines.

Hai-Yan DONG ; Jing-Wei SHAO ; Jian-Feng CHEN ; Tao WANG ; Feng-Ping LIN ; Yang-Hao GUO

China Journal of Chinese Materia Medica 2008;33(9):1014-1089

4.Screening of pregnane X receptor activation from ginsenosides.

Yu-Guang WANG ; Hao-Sheng LIU ; Xian-Xie ZHANG ; Yong XIAO ; Bei-Bei LU ; Zeng-Chun MA ; Qian-De LIANG ; Xiang-Lin TANG ; Cheng-Rong XIAO ; Hong-Ling TAN ; Bo-Li ZHANG ; Yue GAO

Acta Pharmaceutica Sinica 2013;48(1):144-148

5.Coexpression of PXRLBD with SRC88 and construction of equilibrium dialysis model of screening PXR ligands.

Shan-Shan YE ; Chun-Na YU ; Jing CHEN ; Hong-Ying SUN ; Shu-Qing CHEN

Acta Pharmaceutica Sinica 2008;43(4):427-430

7.Inhibitory role of transcription factor COUP-TFII in expression of hTERT in HeLa cells.

Qiang WANG ; Zeng-liang BAI ; Li XUAN ; Lin HOU ; Bo ZHANG

Chinese Medical Sciences Journal 2004;19(3):157-163

8.Establishment of in vitro evaluation model for CYP2B6 induction and its application to screen inducers among TCMs.

Cong XU ; Si-Yun XU ; Hai-Hong HU ; Lu-Shan YU ; Su ZENG

Acta Pharmaceutica Sinica 2013;48(1):119-124

10.Kaempferol activates human steroid and xenobiotic receptor-mediated cytochrome P450 3A4 transcription.

Dong-ying LIU ; Hui-juan ZHU ; Yi-fan ZHENG ; Xin-qiang ZHU

Journal of Zhejiang University. Medical sciences 2006;35(1):14-17

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 19 , 1/2 Show Home Prev Next End page: GO